SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-030740
Filing Date
2021-02-05
Accepted
2021-02-05 16:39:04
Documents
15
Period of Report
2021-02-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d112075d8k.htm   iXBRL 8-K 28416
2 EX-1.1 d112075dex11.htm EX-1.1 141703
3 EX-5.1 d112075dex51.htm EX-5.1 8850
7 GRAPHIC g112075g19t46.jpg GRAPHIC 4800
  Complete submission text file 0001193125-21-030740.txt   355311

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA krys-20210202.xsd EX-101.SCH 3074
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20210202_lab.xml EX-101.LAB 18886
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20210202_pre.xml EX-101.PRE 11862
8 EXTRACTED XBRL INSTANCE DOCUMENT d112075d8k_htm.xml XML 3446
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 21596481
SIC: 2836 Biological Products, (No Diagnostic Substances)